Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.54M Sell
58,703
-1,028
-2% -$120K 0.74% 32
2026
Q1
$7.24M Sell
59,731
-3,751
-6% -$433K 0.77% 32
2025
Q4
$6.74M Sell
63,482
-22,727
-26% -$2.13M 0.68% 35
2025
Q3
$7.3M Sell
86,209
-7,306
-8% -$602K 0.63% 37
2025
Q2
$7.48M Sell
93,515
-6,028
-6% -$479K 0.69% 33
2025
Q1
$9.02M Sell
99,543
-10,058
-9% -$939K 0.86% 29
2024
Q4
$11M Sell
109,601
-890
-0.8% -$91.8K 0.99% 22
2024
Q3
$12.6M Buy
110,491
+3,472
+3% +$412K 1.16% 19
2024
Q2
$13.3M Buy
107,019
+64
+0.1% +$8.24K 1.28% 16
2024
Q1
$11M Buy
106,955
+1,934
+2% +$238K 1.15% 20
2023
Q4
$11.5M Buy
+105,021
New +$10.9M 1.13% 19

Other funds holding MRK

TritonPoint Wealth's MRK Position: Q2 2026 in Review

TritonPoint Wealth reduced its Merck (MRK) stake by 1.7% in Q2 2026, selling an estimated $120K and leaving 58,703 shares worth $7.54M. The position accounts for 0.74% of the portfolio, ranked #32.

TritonPoint Wealth first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.3M in Q2 2024. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • TritonPoint Wealth held 58,703 shares of Merck worth $7.54M as of Q2 2026.
  • TritonPoint Wealth sold 1,028 Merck shares in Q2 2026, an estimated $120K.
  • Merck made up 0.74% of TritonPoint Wealth's portfolio in Q2 2026, its #32 holding.
  • TritonPoint Wealth first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • TritonPoint Wealth's Merck position peaked at $13.3M in Q2 2024.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TritonPoint Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.